Companies / IDX

INTEGRAL DIAGNOSTICS LIMITED

ASX:IDXHealth Care Equipment & Services
373.1M shares on issueASX (delayed) · as of 28 July 2026$2.05price · delayed$764.8Mmarket cap · indicative
B
Dilution grade

Share count grew 60% in 24 months

Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)59.5%
Raise cadence (24m)0 cash raises
Options & rights overhang1.1% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

INTEGRAL DIAGNOSTICS LIMITED's ordinary share count grew 59.5% between April 2024 and April 2026, to 373M shares. The company did not raise capital by placements, rights issues or SPPs in that period. Options and rights on issue could convert into 4M new shares, equal to 1.1% of the current share count, with 0% in the money at the current share price. The company does not have a current quarterly cash report on record, so no quarterly cash balance or funding-runway figure is disclosed. No proposed securities issues (Appendix 3B) are currently pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
1.1%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
—
Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 373.1M per ASX (delayed) (28 July 2026).
263.2M303.5M343.9MDec 24Sept 25July 26

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
1 July 20263G · unquotedORDINARY FULLY PAID373.1MAppendix 3G
2 Apr 20263H · cancellationIDX : ORDINARY FULLY PAID372.9MAppendix 3H
2 Apr 20262A · quoted issueIDX : ORDINARY FULLY PAID373.1MAppendix 2A
22 Jan 20263H · cancellationIDX : ORDINARY FULLY PAID372.9MAppendix 3H
22 Dec 20253G · unquotedORDINARY FULLY PAID372.9MAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

1.1%
Total overhang · of current shares
0.0%
In the money · at current price
4.1M
Potential new shares
—
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
1 July 2026Ian KadishOther38k——3Y notice
24 June 2026James Tobias HallBuy51k——3Y notice
11 June 2026James Tobias HallBuy12k——3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

23 July 2026Re-issued IDX FY26 Results Conference Call
23 July 2026IDX FY26 Results Conference Call
1 July 2026Change of Director's Interest Notice - Dr Ian Kadish
1 July 2026Notification regarding unquoted securities - IDX
25 June 2026Change of Director's Interest Notice - Toby Hall
23 June 2026Becoming a substantial holder
19 June 2026Release of Ordinary Shares from Escrow
12 June 2026Change of Director's Interest Notice - Toby Hall
9 June 2026Response to Media Reporting in WA
2 June 2026Becoming a substantial holder
21 May 2026Ceasing to be a substantial holder
19 May 2026Becoming a substantial holder
5 May 2026Becoming a substantial holder from WAM/WMI/WAX
4 May 2026Becoming a substantial holder
2 Apr 2026Change of Director's Interest Notice - Toby Hall
2 Apr 2026Application for quotation of securities - IDX
2 Apr 2026Notification of cessation of securities - IDX
1 Apr 2026Final Director's Interest Notice
25 Mar 2026Update - Dividend/Distribution - IDX
24 Mar 2026$PCommencement Date for New MD & CEO

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.